SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-C Report by Issuer of Securities Quoted on NASDAQ Interdealer Quotation System Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder NORTH AMERICAN BIOLOGICALS, INC. (Exact name of issuer as specified in charter) 5800 Park of Commerce Boulevard, N.W., Boca Raton, Florida 33487 (Address of principal executive offices) Issuer's telephone number, including area code: (407) 989-5800 I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of security: Common Stock, par value $.10 per share. 2. Number of shares outstanding before the change: 16,401,010. 3. Number of shares outstanding after the change: 19,101,010. 4. Effective date of change: October 14, 1994. 5. Method of change: Issuance of additional shares. Brief description of transaction: On October 14, 1994, the issuer issued 2,700,000 shares of Common Stock in connection with a public offering underwritten by Raymond James & Associates, Inc. and NatWest Securities Limited. Date: November 13, 1995 /s/ Alfred J. Fernandez ----------------------------- (Officer's signature) Vice President Finance and Chief Financial Officer ------------------------------ (Officer's title)